Randomized Clinical Trial to Assess the Efficacy and Safety of Concomitant Use of Rifampicin and Efavirenz 600 X 800mg

Clinical trial NCT00533390 · TERMINATED

Trial details

NCT number: NCT00533390
Sponsor: Oswaldo Cruz Foundation
Status: TERMINATED
Phase: Phase 4
Study type: INTERVENTIONAL

Tuberculosis HIV Infections

Start date: 2007-01-01
Primary completion: 2012-10-01
Enrollment: 130

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.